Corvus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.

About CRVS

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. 

CEO
Richard A. Miller
CEORichard A. Miller
Employees
31
Employees31
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2014
Founded2014
Employees
31
Employees31

CRVS Key Statistics

Market cap
247.33M
Market cap247.33M
Price-Earnings ratio
-3.78
Price-Earnings ratio-3.78
Dividend yield
—
Dividend yield—
Average volume
999.40K
Average volume999.40K
High today
$3.80
High today$3.80
Low today
$3.61
Low today$3.61
Open price
$3.68
Open price$3.68
Volume
703.77K
Volume703.77K
52 Week high
$10.00
52 Week high$10.00
52 Week low
$1.41
52 Week low$1.41
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.